Sanify Healthcare India

Tag: SGLT2 inhibitors

What medication is replacing metformin for type 2 diabetes?
  • 30 Jan 2026
  • Arjun Deshpande

What medication is replacing metformin for type 2 diabetes?

Metformin is no longer the only first-choice diabetes drug. Newer medications like GLP-1 agonists and SGLT2 inhibitors now offer better heart, kidney, and weight benefits - changing how doctors treat type 2 diabetes in 2026.

View More

Search

Latest Posts

Red Flags After Total Knee Replacement: What Not to Ignore

Red Flags After Total Knee Replacement: What Not to Ignore

Aggressive Cancer: Unpacking the Fastest Killers

Aggressive Cancer: Unpacking the Fastest Killers

How Much Weight Can You Lose on Ozempic? Real Results and What to Expect

How Much Weight Can You Lose on Ozempic? Real Results and What to Expect

The Best Prescription for Weight Loss: What You Need to Know

The Best Prescription for Weight Loss: What You Need to Know

What Is the 3-3-3 Rule for Weight Loss? Simple Steps That Actually Work

What Is the 3-3-3 Rule for Weight Loss? Simple Steps That Actually Work

Categories

  • IVF 20
  • Mental Health 19
  • Orthopedic Surgery 16
  • Ayurveda 14
  • Health and Wellness 11
  • Cancer Treatment 11
  • Weight Loss 11
  • Diabetes 10
  • Medical Tourism 9
  • Cardiac Surgery 9

Tags

    mental health therapy medical tourism cancer treatment weight loss clinics fertility treatment knee replacement online pharmacy weight loss Ayurveda diabetes medication IVF treatment ADHD side effects pancreatic cancer dental implants IVF health tips IVF risks knee replacement recovery
Sanify Healthcare India

About

Diabetes

Menu

  • About Us
  • Terms of Service
  • Privacy Policy
  • DPDP
  • Contact Us

Popular

  • Red Flags After Total Knee Replacement: What Not to Ignore

    Red Flags After Total Knee Replacement: What Not to Ignore

    23 Apr, 2025

  • Aggressive Cancer: Unpacking the Fastest Killers

    Aggressive Cancer: Unpacking the Fastest Killers

    28 Feb, 2025

©2026 sanifyhealthcare.co.in. All rights reserved